| Literature DB >> 31473338 |
Lance K Blevins1, Robert B Crawford1, Anthony Bach2, Michael D Rizzo3, Jiajun Zhou4, Joseph E Henriquez5, D M Isha Olive Khan5, Sera Sermet1, Lora L Arnold6, Karen L Pennington6, Nathalia P Souza6, Samuel M Cohen7, Norbert E Kaminski8.
Abstract
The toxicity of dietary E 171, a food grade titanium dioxide was evaluated. A recent study reported rats receiving E 171 in water developed inflammation and aberrant crypt foci (ACF) in the gastrointestinal tract. Here, rats received food containing E 171 (7 or 100 days). The 100-day study included feeding E 171 after dimethylhydrazine (DMH) or vehicle only pretreatment. Food consumption was similar between treatment groups with maximum total cumulative E 171 exposure being 2617 mg/kg in 7 days and 29,400 mg/kg in 100 days. No differences were observed due to E 171 in the percentage of dendritic, CD4+ T or Treg cells within Peyer's patches or the periphery, or in cytokine production in plasma, sections of jejunum, and colon in 7- or 100-day E 171 alone fed rats. Differences were observed for IL-17A in colon (400 ppm E 171 + DMH) and IL-12p70 in plasma (40 ppm E 171 + DMH). E 171 had no effect on histopathologic evaluations of small and large intestines, liver, spleen, lungs, or testes, and no effects on ACF, goblet cell numbers, or colonic gland length. Dietary E 171 administration (7- or 100-day), even at high doses, produced no effect on the immune parameters or tissue morphology.Entities:
Keywords: Dietary titanium dioxide; E 171; Gastrointestinal inflammation; Intestinal carcinogenesis; T(regulatory) cells
Mesh:
Substances:
Year: 2019 PMID: 31473338 PMCID: PMC6775638 DOI: 10.1016/j.fct.2019.110793
Source DB: PubMed Journal: Food Chem Toxicol ISSN: 0278-6915 Impact factor: 6.023